0000899243-21-040821.txt : 20211020 0000899243-21-040821.hdr.sgml : 20211020 20211020183615 ACCESSION NUMBER: 0000899243-21-040821 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210610 FILED AS OF DATE: 20211020 DATE AS OF CHANGE: 20211020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lee Christopher G CENTRAL INDEX KEY: 0001887223 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40053 FILM NUMBER: 211335165 MAIL ADDRESS: STREET 1: 7353 COMPANY DRIVE CITY: INDIANAPOLIS STATE: IN ZIP: 46237 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apria, Inc. CENTRAL INDEX KEY: 0001735803 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 824937641 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7353 COMPANY DRIVE CITY: INDIANAPOLIS STATE: IN ZIP: 46237 BUSINESS PHONE: 800-990-9799 MAIL ADDRESS: STREET 1: 7353 COMPANY DRIVE CITY: INDIANAPOLIS STATE: IN ZIP: 46237 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-10 0 0001735803 Apria, Inc. APR 0001887223 Lee Christopher G C/O APRIA, INC. 7353 COMPANY DRIVE INDIANAPOLIS IN 46237 0 1 0 0 Chief Accounting Officer Common Stock 2021-08-10 4 M 0 2700 4.67 A 2700 D Common Stock 2021-08-10 4 F 0 1205 30.51 D 1495 D Common Stock 2021-08-11 4 S 0 1059 30.55 D 436 D Common Stock 2021-08-11 4 S 0 436 31.60 D 0 D Common Stock 2021-09-20 4 M 0 2700 4.67 A 2700 D Common Stock 2021-09-20 4 F 0 1155 37.29 D 1545 D Common Stock 2021-09-23 4 S 0 1179 36.57 D 366 D Common Stock 2021-09-23 4 S 0 366 37.22 D 0 D Common Stock 2021-10-18 4 M 0 2700 4.67 A 2700 D Common Stock 2021-10-18 4 F 0 1176 34.17 D 1524 D Restricted Stock Units 2021-06-10 4 A 0 1854 0.00 A Common Stock 1854 1854 D Stock Appreciation Right 4.67 2021-08-10 4 M 0 2700 0.00 D 2027-03-09 Common Stock 2700 5746 D Stock Appreciation Right 4.67 2021-09-20 4 M 0 2700 0.00 D 2027-03-09 Common Stock 2700 3046 D Stock Appreciation Right 4.67 2021-10-18 4 M 0 2700 0.00 D 2027-03-09 Common Stock 2700 346 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2021. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $30.03 to $31.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $31.14 to $32.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $36.09 to $37.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $37.09 to $37.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer ("Common Stock"). The restricted stock units will be settled in either Common Stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee. These restricted stock units vest in three equal annual installments beginning on June 10, 2022, subject to the Reporting Person's continued employment on the applicable vesting date. These stock appreciation rights are fully vested. /s/ Timothy Maloche, as Attorney-in-Fact 2021-10-20